Loading…
Alpa Laboratories (ALPA)₹56.58+1.16%Pharmaceuticals
At the end of the Jun 2026 quarter, Alpa Laboratories' shareholders were: promoters 57.21%, FIIs 0.35%, DIIs 0.07%, public 42.37%. Promoter holding is unchanged on the quarter. FII holding is down 0.01 percentage points from 0.36% a year earlier. It had 17,642 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 57.31% | 57.31% | 57.31% | 57.31% | 57.31% | 57.31% | 57.31% | 57.31% | 57.31% | 57.31% | 57.21% | 57.21% |
| FIIs | 0.11% | 0.95% | 0.50% | 0.36% | 0.74% | 0.35% | 0.40% | 0.36% | 0.35% | 0.36% | 0.38% | 0.35% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.07% |
| Public | 42.58% | 41.74% | 42.19% | 42.33% | 41.95% | 42.34% | 42.29% | 42.33% | 42.34% | 42.33% | 42.41% | 42.37% |
| Number of shareholders | 18,564 | 18,681 | 18,689 | 18,115 | 18,884 | 19,205 | 18,871 | 18,850 | 18,541 | 18,235 | 17,899 | 17,642 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Paresh Chawla | Promoter | 34.24% | 0.00 |
| Shitul Shah | Promoter | 10.10% | 0.00 |
| Bakulesh Shah | Promoter | 4.92% | 0.00 |
| Rima Shah | Promoter | 3.67% | 0.00 |
| Rupal Shah | Promoter | 2.68% | 0.00 |
| Soni Chawla | Promoter | 1.56% | 0.00 |
| Asha Chawla | Promoter | 0.00% | 0.00 |
| Bakulesh Chandulal Shah Huf | Promoter | 0.00% | 0.00 |
| Mahendra Singh Chawla | Promoter | 0.00% | 0.00 |
| Pravin Shah | Promoter | 0.00% | 0.00 |
Promoters held 57.21% of Alpa Laboratories at the end of the Jun 2026 quarter, down 0.10 percentage points from 57.31% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.35% (down 0.03 percentage points from 0.38% a quarter earlier) and domestic institutions (DIIs) held 0.07% (up 0.07 percentage points from 0.00% a quarter earlier).
Alpa Laboratories had 17,642 shareholders at the end of the Jun 2026 quarter, against 18,850 a year earlier.